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Abstract: As the atrophic posterior maxilla often presents serious limitations for dental implant
procedures, a minimally invasive technique was proposed. The study aimed to retrospectively
evaluate the outcomes of short and ultra-short locking-taper implants, placed in combination with a
modified osteotome sinus floor elevation procedure (internal sinus lift technique) in the posterior
maxilla. A total of 31 patients received 51 locking-taper implants. Clinical and radiographic
examinations were performed before treatment, at loading time, and after three years. Seven implants
of 8.0 mm, 23 implants of 6.0 mm, and 21 implants 5.0 mm in length were rehabilitated with
single-crown restorations. Implant survival at three-year follow-up was 96.08%. Pre-operative
residual crestal bone height of 5.2 (1.41) (median (interquartile range)) mm increased to 7.59 (1.97)
mm at the 36-month follow-up, with an average intra-sinus bone height gain of 3.17 ± 1.13 (mean
± standard deviation) mm. Mean peri-implant crestal bone loss was 0.29 (0.46) mm and mean first
bone-to-implant contact point shifted apically to 0.12 (0.34) mm. It can be suggested with confidence
that implants used in the study, placed in conjunction with an internal sinus floor elevation technique,
can be restored with single crowns as a predictable treatment for the edentulous regions of the
posterior maxilla.
Keywords: bone gain; crestal bone height; implant survival; internal sinus lift; maxilla; short implant;
single crown; ultra-short implant
1. Introduction
Reduced bone volumes characterized by severe atrophy and increased sinus pneumatization are
often encountered in the posterior maxilla, especially in sites involved in extraction of periodontally
compromised teeth [1]. A radiological study [2] reported that edentulous first and second molar sites
showed a mean residual crestal bone height (RCBH) of 3.3 ± 2.2 mm and 4.5 ± 2.4 mm, respectively;
furthermore, the prevalence of sites with RCBH less than 5 mm in these areas was 73.1% and 54.2%,
respectively [2].
As bone in the posterior maxilla has poor quality and large marrow spaces, its anatomical and
physiological features often represent serious restrictions. To overcome these limitations, a number
of procedures, such as lateral or transcrestal maxillary sinus floor elevation [3] and bone substitutes
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(autografts, allografts, xenografts, and synthetic biomaterials) [4], were proposed for sinus grafting
and for augmenting bone volumes in the posterior maxilla, to enable dental implant placement [5–8].
Though these procedures often presented a high rate of implant survival and bone levels’ stability
over time [9], they were not always well accepted by the patients because of expense, increased
post-operative morbidity, high risk of infection (fistula with pus or abscess, frequently caused by
infection of the grafted material), and prolonged healing time [10–12].
In 1994, a less invasive procedure called osteotome sinus floor elevation (OSFE) was proposed
by Summers [13–16]. Although this procedure was historically recommended and was proved to be
effective for patients with at least 7 mm of bone below the sinus floor, recent studies have established
comparable implant survival in the case of sites with an even lower RCBH [17–19]. Nevertheless, when
the limit of 5.0 mm of RCBH was exceeded, implant survival seemed to significantly drop [20–23] from
96% to 85.7% [20]. Furthermore, a meta-regression analysis [24] postulated that standard implants
(longer than 8.0 mm), placed simultaneously with the OSFE procedure in implant sites with RCBH less
than 5.0 mm beneath the sinus, seemed to be at a greater risk for failure.
Following the development of innovative implant design and surface textures, literature reviews
and meta-analysis of the last decades [25–27] have supported the use of implants 6.0 mm and 8.0 mm in
length (defined as short implants) in the treatment of resorption in the posterior maxilla. These recent
studies [25–27] have also reported high implant survival for these implants, placed via a crestal
approach, and using the OSFE technique in patients with even less than 5.0 mm of RCBH. Though these
investigations have considered short implants supporting different types of restorations, the evidence
concerning clinical outcomes of short implants, placed in conjunction with an OSFE technique and
supporting nonsplinted single crowns in the atrophic posterior maxilla, remains scarce. It is, however,
suggested that the use of single-crown restorations confers additional potential benefits, such as better
oral hygiene access, improved acceptance, and patient comfort [28].
With due consideration for the relatively short-term follow-up, the study aimed to retrospectively
evaluate the outcomes of locking-taper implants, 8.0 mm, 6.0 mm, and 5.0 mm in length, placed in
combination with a modified osteotome sinus floor elevation procedure, called internal sinus lift
technique (ISL). We hypothesized that these implants, restored with single crowns, can represent a
successful therapy in cases of extremely reduced RCBH.
2. Materials and Methods
2.1. Study Design and Inclusion Criteria
The patients were recruited and treated, between January 2014 and January 2015, with
implant-supported single crowns for edentulism (tooth loss caused by trauma, caries, or periodontal
disease) in the posterior maxilla at the Dental and Maxillo-Facial Surgery Clinic at the University of
Verona (Italy). A retrospective study with a 36-month follow-up [29,30] was conducted between June
and September 2018. The University Institutional Review Board approved the retrospective study
(Protocol “SINUSLIFT”, 23/05/18). The nature and aim of the study, together with the anonymity in
the scientific use of data, were clearly explained in a written, informative consent form, which was
signed by every patient. All clinical procedures were performed in accordance with the Declaration of
Helsinki and the good clinical practice guidelines for research on human beings.
To be included in the study, patients had to have at least one 5.0 mm, 6.0 mm, or 8.0 mm in length
locking-taper implant [29,30], which had been placed in a partially edentulous posterior maxilla in
combination with an ISL procedure and which supported a single crown. In addition, the RCBH must
have been equal to or less than 6.0 mm and a crestal bone thickness must have been of at least 6 mm,
as determined by CBCT (cone beam computed tomography) scan measurements.
Exclusion criteria considered were: The presence of active infection at an implant site; ASA
status III (according to the American Society of Anesthesiologists’ classification [31]), that is severe
systemic diseases or substantive functional limitations which contraindicated implant surgery (such as
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drug or alcohol abuse, uncontrolled diabetes mellitus, immunosuppression or immunodepression,
severe autoimmune diseases, treatment or past treatment with intravenous amino-bisphosphonates for
metastatic bone diseases, radiotherapy to head or neck within two years prior to treatment, history of
malignancy or chemotherapy within the previous year, treatment with oral amino-bisphosphonates
for more than three years, morbid obesity, active hepatitis, severe renal disease, severe cardiovascular
conditions, recent history of myocardial infarction (MI) or transient ischemic attack (TIA)); ASA status
IV, V, and VI; history of sinus surgery; acute or chronic maxillary sinusitis; oro-antral fistulae; untreated
periodontitis; poor oral hygiene and motivation; current pregnancy or lactation; heavy smoking (more
than 25 cigarettes per day) [32]; and severe clenching or bruxism.
2.2. Surgical Protocol
All treatments and visits were carried out by two experienced periodontal surgeons.
Pre-operative assessment consisted of clinical and radiographic evaluation. Panoramic radiographs
were used for initial screening, followed by CBCT scans to precisely quantify the amount of available
bone under the maxillary sinus. Furthermore, an intraoral radiograph performed with parallel
technique was made to determine the baseline RCBH and to allow future comparison with the CBCT
scan measurement. When the operative site involved more than one tooth, diagnostic casts for
the creation of a mucosal supported surgical guide were made. One month before surgery each
patient underwent a full-mouth session of scaling and root planing, using mechanical and hand
instrumentation, and received personalized oral hygiene instructions [33].
A pre-operative medication consisting of 2 g of Augmentin (875 mg amoxicillin plus 125 mg
clavulanic acid), or 1 g of Klacid (Clarithromycin 500 mg) if allergic to penicillin, was given one hour
before surgery [34]. All surgical procedures were performed under local anaesthesia, using only
Articain 4% with adrenaline 1:100,000 (Citocartin) or Articain 4% with adrenaline 1:100,000 (Citocartin)
associated with oral sedation (Halcion 0.25 mg).
After a midcrestal incision, buccal and palatal full-thickness flaps were reflected. Vertical releasing
incisions were made only if necessary. The recipient sites were marked with a 2.0-mm-round drill.
If the edentulous space involved more than one tooth, the mark was made in accordance with the
pre-prepared surgical templates. The osteotomy was initiated using a 2.0-mm-diameter pilot drill to
a depth of 0.5 to 1.0 mm from the sinus floor, while being guided by pre-operative radiographs and
the CBCT. The expansion of the osteotomy sites continued with successively larger dedicated manual
reamers to create an osteotomy of 5.0 mm diameter and 1.0 mm from the sinus floor. The sinus floor
fracture was obtained by inserting a 5.0-mm sinus lift osteotome into the osteotomy to the level of the
sinus floor and gently tapping the osteotome with a mallet to create a hairline fracture in the floor of
the sinus. Great attention was given to avoid perforation of the sinus membrane. After completion
of this procedure, the integrity of the Schneiderian membrane was manually confirmed by gentle
sounding with a blunt tipped depth gauge. The membrane was then elevated by placing a synthetic
bone graft material into a syringe and injecting it into the osteotomy. As the column of graft material
was advanced in the osteotomy, it gently lifted the sinus membrane to the desired height. Implants
were placed immediately after the sinus elevation using an implant inserter and using the implant to
further raise the sinus floor.
Short implants (8.0 and 6.0 mm in length) or ultra-short implants (5.0 mm in length) were utilized
in this study. The locking-taper (Morse taper or Morse cone) dental implant system (Bicon Dental
Implants, Boston, MA, USA, designed in 1985) has an implant-abutment interface (IAI) connection,
which is impervious to bacterial penetration or infiltration [35]. The implant system also includes a
convergent crest module, platform switching, plateau root-form design, and an Integra CPTM surface
(Hydroxylapatite treated and acid etched).
Before implant placement, a sinus lift temporary abutment was inserted into the implant to
prevent the implant from migrating into the sinus. The flaps were accurately sutured, allowing for a
primary wound closure, and all implants were left submerged during the following six-month healing
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period. Immediately after flap closure, periapical radiographs, which would serve as baseline for
future comparison, were made with the paralleling technique [29,30]. Figure 1a–g reports a schematic
drawing of the implant procedure.Materials 2020, 13, 2208 4 of 18 
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Figure 1. (a–g). Schematic drawing of internal sinus lift (ISL) technique with Bicon dental implant. (a) 
Note the minimal residual bone depth of 5.0-8.0 mm. (b) Prepare osteotomy beginning with the 2.0-
mm pilot drill. (c) Continue to prepare osteotomy with successively larger reamers to the extent that 
1.0-2.0 mm of undisturbed bone remains below the sinus floor (a 5.0-mm-diameter implant has been 
chosen for this case). (d) Place a 5.0-mm sinus lift osteotome into the osteotomy and engage the area 
slightly below the sinus floor. (e) Gently tap the osteotome and create a hairline fracture around the 
floor of the osteotomy. (f) Place a bone graft material into the socket. (g) Introduce the implant into 
the osteotomy site with the implant inserter and use the implant to raise the sinus floor. 
Patients received detailed post-operative instructions, along with antibiotic and analgesic 
prescriptions. After one week, patients were monitored for evidence of post-operative swelling 
and/or headaches. The sutures were removed after two weeks, and patients were instructed not to 
use removable dentures during the six-month healing period. 
2.3. Prosthetic Protocol and Follow-Up Evaluation 
After six months, implants were surgically uncovered, healing abutments were placed, and the 
mucosal flaps re-adapted and sutured around the healing abutments. After three weeks of soft tissue 
healing, definitive impressions were taken, using a polyether material. Definitive single-crown 
porcelain or composite restorations were delivered within two weeks. The technique used was the 
IAC (Integrated Abutment Crown), in which the abutment and the crown material are extra-orally, 
chemo-mechanically bonded; therefore, there was no need for cement, and the implant and IAC are 
connected with a screwless locking-taper connection [36]. 
A maintenance program was designed to provide patients a professional oral hygiene session 
every four months [33] and home care procedures were reinforced. At each recall appointment, 
occlusion was assessed and adjusted as necessary; prosthetic restorations were checked for loosening, 
chipping, or other types of complications. Clinical assessment of peri-implant soft tissues and 
Figure 1. (a–g). Schematic drawing of internal sinus lift (ISL) technique with Bicon dental implant.
(a) Note the minimal residual bone depth of 5.0-8.0 mm. (b) Prepare osteotomy beginning with the
2.0-mm pilot drill. (c) Continue to prepare osteotomy with successively larger reamers to the extent
that 1.0-2.0 mm of undisturbed bone remains below the sinus floor (a 5.0-mm-diameter implant has
been chosen for this case). (d) Place a 5.0-mm sinus lift osteotome into the osteotomy and engage the
area slightly below the sinus floor. (e) Gently tap the osteotome and create a hairline fracture around
the floor of he osteotomy. (f) Place a bon graft mat rial into the sock t. (g) Introduce the implant into
the osteotomy site with the implant inserter and use the implant to raise the sinus floor.
Patients received detailed post-operative instructions, alo g with antibiotic and analgesic
prescriptions. After one week, patients were monitored for evidence of post-operative swelling
and/or headaches. The sutures were removed after two weeks, and patients were instructed not to use
removable dentures during the six-month healing period.
2.3. Prosthetic Protocol and Follow-Up Evaluation
After six mo ths, i plants were surgically uncovered, healing abutments were placed, and
the mucosal flaps re-adapted and sutur d around the ealing abutments. After thr e eeks of soft
tissue healing, definitive i pressions were taken, using a polyet er material. Definitive single-crown
porcelain or composite restorations were delivered within two weeks. The technique used was the
IAC (Integrated Abutment Crown), in which the abutment and the crown material are extra-orally,
chemo-mechanically bonded; therefore, there was no need for cement, and the implant and IAC are
connected with a screwless locking-taper connection [36].
A maintenance program was designed to provide patients a pr fessional oral hygiene session every
four months [33] and home care procedures were reinforced. At each recall appointment, occlusion
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was assessed and adjusted as necessary; prosthetic restorations were checked for loosening, chipping,
or other types of complications. Clinical assessment of peri-implant soft tissues and radiographic
examinations were performed after three years of follow-up from loading time [29,30]. By way of
illustration, Figures 2–4 report some radiographic cases.
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Figure 2. (a–f). Clinical case: Single implant placed in 1.6 site. (a) Clinical photograph before implant 
placement, missing first molar. (b) Pre-operative radiograph before implant placement in site 1.6. See 
minimal bone in implant site. (c) Radiograph obtained at implant placement. See short implant with 
sinus lift temporary abutment designed to prevent displacement of the implant into the sinus, also 
see augmented sinus floor. (d) Radiograph obtained at time of loading. See augmented sinus floor, 
also see the radiolucent area in the crown of the second bicuspid, which was a lost restoration. (e) 
Radiograph obtained at three-year follow-up. See stable bone levels, also see the replaced restoration 
in the crown of the second bicuspid. (f) Clinical photograph at three-year follow-up. See stable clinical 
conditions. 
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Figure 3. (a–f). Clinical case: Four implants placed in 1.4, 1.5, 1.6, and 1.7 sites. (a) Clinical photograph 
before implants placement. (b) Pre-operative radiograph before implants placement in sites 1.4, 1.5, 
1.6, and 1.7. See minimal bone levels. (c) Radiograph obtained at time of implants placement. Two of 
Figure 2. (a–f). Clinical case: Single implant placed in 1.6 site. (a) Clinical photograph before implant
placement, missing first molar. (b) Pre-operative radiograph before implant placement in site 1.6. See
minimal bone in implant site. (c) Ra io raph obtained t i plant placeme t. S e short implant with
sinus lift temporary abutment designed to prevent displacement of the implant into the sinus, also see
augmented sinus floor. (d) Radiograph obtained at time of loading. See augmented sinus floor, also see
the radioluce area i the crown of the seco d bicuspid, which w s a lost restor tion. (e) Radiograph
obtained at three-year follow-up. See stable bone levels, also see the replaced restoration in the crown
of the second bicuspid. (f) Clinical photograph at three-year follow-up. See stable clinical conditions.
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Figure 3. (a–f). Clinical case: Four implants placed in 1.4, 1.5, 1.6, and 1.7 sites. (a) Clinical photograph 
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Figure 3. (a–f). Cl nic l case: Four implants place in 1.4, 1.5, 1.6, d 1.7 sites. (a) Clinical photograph
before implants placement. (b) Pre-operative radiograph before i plants placement in sites 1.4, 1.5,
1.6, and 1.7. See minimal bone levels. (c) Radiograph obtained at time of implants placement. Two of
the implants have sinus lift abutments. Augmented sinus visible. (d) Implants restored. Radiograph
obtained at time of loading. (e) Radiograph obtained at the three-year follow-up. See stable bone levels
both for sites with augmented sinus floor and for sites without it. (f) Clinical photograph at three-year
follow-up. See stable clinical conditions.
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before implants placement. (b) Pre-operative radiograph before implants placement in sites 2.5, 2.6, 
and 2.7. (c) Radiograph obtained at implants placement. See augmented sinus floor. (d) Radiograph 
obtained at loading time. Another implant was placed in site 2.4 (the extracted tooth had grade 3 
mobility and was extremely compromised). Site 2.4 was temporarily restored using the implant in 2.5 
site to support a cantilever prosthesis. (e) Radiograph obtained at loading time. See definitive 
restorations for all implants. (f) Radiograph obtained at three-year follow-up. See stable bone levels. 
(g) Clinical photograph at three-year follow-up. See stable clinical conditions. 
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Implant lengths considered in this study were 8.0 mm, 6.0 mm, and 5.0 mm; implant diameters 
were 4.0 mm, 4.5 mm, 5.0 mm, and 6.0 mm. Covariates included were: Sex, age, smoking history, 
history of periodontal disease, ASA status, number of oral hygiene sessions per year, interproximal 
access for oral hygiene, tooth site, prosthetic material, and crown-to-implant ratio (CIR) [29,30]. 
The main outcome was implant survival after three years of follow-up. Implant failure was 
considered as the need for implant removal either before loading (due to no osseointegration) or after 
loading (due to excessive bone loss). Implant survival was considered as the implant’s state of being 
in function at the three-year follow-up evaluation, that is, symptom-free, without mobility, 
radiolucency, or bone loss so severe as to warrant implant removal [29,37–39]. 
A secondary outcome included variations of peri-implant bone levels and sinus floor level, 
which were measured through digitally scanned intraoral radiographs, performed with parallel 
Figure 4. (a–g). Clinical case: Four implants placed in 2.4, 2.5, 2.6, and 2.7 sites. (a) Clinical photograph
before implants placement. (b) Pre-operative radiograph before implants placement in sites 2.5, 2.6,
and 2.7. (c) Radiograph obtained at implants placement. See augmented sinus floor. (d) Radiograph
obtained at loading time. Another implant was placed in site 2.4 (the extracted tooth had grade 3
mobility and was extremely compromised). Site 2.4 was temporarily restored using the implant in
2.5 site to support a cantilever prosthesis. (e) Radiograph obtained at loading time. See definitive
restorations for all implants. (f) Radiograph obtained at three-year follow-up. See stable bone levels.
(g) Clinical photograph at three-year follow-up. See stable clinical conditions.
2.4. Study Variables and Outcomes
Implant lengths considered in this study were 8.0 mm, 6.0 mm, and 5.0 mm; implant diameters
were 4.0 mm, 4.5 mm, 5.0 mm, and 6.0 mm. Covariates included were: S x, age, smoking history,
history of pe i dontal disease, ASA status, number of oral hygiene sessions per year, interproximal
access for oral hygiene, tooth site, prosthetic material, and crown-to-implant ratio (CIR) [29,30].
The main outcome was implant survival after three years of follow-up. Implant failure was
considered as the need for implant removal either before loading (due to no osseointegration) or after
loading (due to excessive bone loss). Implant survival was considered as the implant’s state of being in
function at the three-year follow-up evaluation, that is, symptom-free, without mobility, radiolucency,
or bone loss so severe as to warrant implant removal [29,37–39].
A secondary outcome included variations of peri-implant bone levels and sinus floor level,
which were measured through digitally scanned intraoral radiographs, performed with parallel
technique [40], using Rinn centering devices (Rinn XCP Posterior Aiming Ring-Yellow, Dentsply, Elgin,
IL, USA), immediately after implant placement, at healing abutment placement, at prosthetic loading,
and after three years of loading. The implant-abutment interface (IAI) was taken as a reference for
measurements [29].
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A descriptive analysis of crestal bone level (CBL, average bone level around implants at mesial
and distal sides, in mm) and first bone-to-implant contact (F-BIC, in mm) [41–43], along with their
variations ∆CBL (average bone loss) and ∆F-BIC (average apical shift of the first bone-to-implant
contact point position) was conducted. These values were determined based on changes that took
place between loading time and the three-year follow-up time, according to covariates. CBL was
measured on mesial and distal sides as the linear distance between the IAI and the highest point of the
interproximal bone crest parallel to the lateral sides of the implant body. A positive value was given
when the crest was located coronally to the IAI and a negative value was given when the crest was
located apically to the IAI. F-BIC was defined as the first most coronal bone-to-implant relationship
visible at the first line of contact, on both mesial and distal sides. If F-BIC matched with IAI, the
measurement was 0. If it was located apically, the measurement was a positive value. For every
implant, an average (av) mesial-distal value (av-CBL and av-FBIC) was calculated at each examination
interval [29].
Furthermore, as described in the literature [44], implants were divided into two groups on the
basis of presenting a crown-to-implant ratio (CIR) less than or greater than 2. The crown height was
measured on the radiograph immediately after the prosthetic loading, from the most occlusal point to
the IAI. Anatomical CIR [44] (in which the fulcrum is positioned at the interface between the implant
shoulder and the crown-abutment complex) was calculated by dividing the digital length of the crown
by the digital length of the implant [29].
Sinus floor level (SFL) was measured on the mesial, central, and distal point of each implant, as
the linear distance between the IAI and the sinus floor. For each implant, at each examination interval,
an average (av) mesial-distal-central value for sinus floor level (av-SFL) was calculated. The sum of
av-CBL and av-SFL was calculated as the residual crestal bone height (RCBH). The vertical increase in
height of the implant site (intra-sinus bone height gain, IBHG) was also calculated as the difference of
the RCBH with the pre-operative RCBH, in order to obtain the final crest height [45,46].
Measurements were assessed with the aid of a software program (Rasband, W.S., ImageJ,
U.S. National Institutes of Health, Bethesda, MD, USA) which uses a measuring tool in conjunction
with a magnification tool. To correct the distortion of the radiographic image, the apparent size of
each implant (measured directly on the radiograph) was compared with the actual length of the
implant, to determine with adequate precision the amount of change in the crestal bone around
each implant. The measurements were made to the nearest 0.01 mm [29]. Beyond that, the results
from the pre-operative periapical radiographs were compared with those of pre-operative CBCT
scans. If disagreements were present between the values, the CBCT values were chosen and served
as reference for future comparison with the radiographs. One dentist, who was not involved in the
treatment of the patients, completed all the measurements on periapical radiographs and CBCT scans;
the observation intervals of the radiographs were masked to the examiner. Before the start of the study,
this investigator was calibrated for intra-examiner adequate levels of accuracy and reproducibility
in recording the radiographic parameters. Three radiographs were used for this purpose: Duplicate
measurements for CBL, F-BIC, SFL, and CIR were collected with an interval of 24 h between the first
and second recording. The intra-class correlation coefficients, used as a measure of intra-examiner
reproducibility, had to be greater than 0.8 [29].
After seven days and at the three-year follow-up examination, each patient was asked to quantify the
level of their satisfaction (Figure 5), on a 1-to-10 point visual analogue scale (VAS) [47], with the implant
experience and considering the potential benefits, if they would undergo this type of surgery again.
2.5. Statistical Analysis
For data collection, a database including all patients evaluated in the study was created with
Microsoft Excel. All data analysis was carried out using Stata v.13.0 for Macintosh (StataCorp.,
College Station, TX, USA) [29,48]. The normality assumptions for continuous data were assessed by
using the Shapiro-Wilk test; mean and standard deviation (SD) were reported for normally distributed
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data [mean ± SD], median, and interquartile range (iqr) otherwise (median(iqr)). For categorical
data, absolute frequencies, percentages, and 95% confidence intervals were reported. The association
between categorical variables was tested with χ2 test; if any of the expected values was less than 5,
a Fisher’s exact test was performed. The comparison between the means of continuous variables in two
different times was performed by using paired Student’s “t” test or Wilcoxon matched-pairs signed-rank
test. The comparison between the means of two different groups was performed using unpaired
Student’s “t”, or Wilcoxon rank-sum test. The comparison of the means among more than two groups
was done using one-way analysis of variance (ANOVA) or Kruskal–Wallis equality-of-populations
rank test as appropriate. Bonferroni correction for multiple comparison was applied. Significance level
was set at 0.05.
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3. Results
3.1. Demographics
Thirty-one patients (20 women and 11 men) were includ d for th retrospective study ccording
to inclusion and exclusion criteria. Mean age at placement was 53.59 ± 10.48 years (range 34–75).
Twenty patients (with 37 implants) had lost their teeth due to periodontal disease (in some cases this
was self-reported, in others it was determined through patient’s dental records), while 11 patients
(with 14 implants) had lost their teeth for other reasons.
Of the implants, 41.18% were 5.0 mm, 45.1% were 6.0 mm, and 13.73% were 8.0 mm in length.
Most of the implants (74.51%) were placed in the molar ar a. Implant diamet rs were 4.0 mm (3.92%),
4.5 mm (29.41%), 5.0 mm (56.86%), and 6.0 mm (9.8%), respectively. Of the implants, 39.22% and
60.78% were placed in patients, respectively, with ASA status I and II. All implants were restored
with single crowns, 44 of them with porcelain crowns, and seven with resin crowns. Mean CIR was
1.99 ± 0.44 (range 1.07–2.85). A CIR ≥ 2 prevalence was estimated in 49.02% of the implants. Significant
differences (p = 0.01) for CIR among length groups were found: 1.3 ± 0.15 (range 1.20–1.61), 1.92 ± 0.25
(range 1.42–2.32), and 2.27 ± 0.44 (range 1.07–2.85) for implants 8.0 m, 6.0 m , and 5.0 mm in length.
The implant distribution was analyzed according to length definition (8.0, 6.0, and 5.0 mm).
The overall descriptive statistics for the study variables are presented in Table 1.
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Table 1. Overall characteristics of implants placed: Length-group distribution according to study
variables. Age at follow-up, months at loading/follow-up time, and oral professional hygiene/year are
presented as [mean ± SD]; for all other variables, values are presented as n (%).
VARIABLE
Overall
(N = 51)
5 mm
(N = 21)
6 mm
(N = 23)
8 mm
(N = 7) p-Value
n % n % n % n %
SEX
Male 20 39.22 9 42.86 7 30.43 4 57.14
0.42Female 31 60.78 12 57.14 16 69.57 3 42.86
AGE AT FOLLOW-UP 56.22 ± 18.86 56.68 ± 11.11 58.04 ± 9.99 62.70 ± 9.26 0.35
MONTHS AT LOADING
TIME 11.50 ± 5.54 12.47 ± 5.49 11.30 ± 5.70 9.28 ± 5.18 0.41
MONTHS AT FOLLOW-UP
TIME 42.86 ± 20.33 41.04 ± 17.52 43.73 ± 23.31 45.42 ± 20.14 0.85
SMOKING
No 42 82.35 15 71.43 20 86.96 7 100.00
0.23Yes 9 17.65 6 28.57 3 13.04 0 0.00
ASA STATUS
I 20 39.22 7 33.33 12 52.17 1 14.29
0.17II 31 60.78 14 66.67 11 47.83 6 85.71
ORAL HYGIENE
SESSIONS/YEAR 3.11 ± 1.05 2.95 ± 1.16 3.30 ± 0.97 3.00 ± 1.00 0.52
INTERPROXIMAL ORAL
HYGIENE
No 10 19.61 3 14.29 5 21.74 2 28.57
0.74Yes 41 80.39 18 85.71 18 78.26 5 71.43
HISTORY OF
PERIODONTAL DISEASE
No 14 27.45 5 23.81 8 34.78 1 14.29
0.57Yes 37 72.55 16 76.19 15 65.22 6 85.71
TYPE OF TOOTH
Premolar 13 25.49 5 23.81 3 13.04 5 71.43
0.01Molar 38 75.51 16 76.19 20 86.96 2 28.57
IMPLANT DIAMETER
4 mm 2 3.92 2 9.52 0 0.00 0 0.00
<0.001
4.5 mm 15 29.41 0 0.00 8 34.78 7 100.00
5 mm 29 56.86 14 66.67 15 65.22 0 0.00
6 mm 5 9.8 5 23.81 0 0.00 0 0.00
PROSTHETIC MATERIAL
Resin 7 13.73 5 23.81 1 4.35 1 14.29
0.15Porcelain 44 86.27 16 76.19 22 95.65 6 85.71
CROWN-TO-IMPLANT
RATIO
<2 26 50.98 5 23.81 14 60.87 7 100.00
0.012–2.99 16 31.37 7 33.33 9 39.13 0 0.00
>2.99 9 17.65 9 42.86 0 0.00 0 0.00
3.2. Implant Survival
At the uncovering stage, all the implants were osteo-integrated and no early failures were detected.
Two implants were lost after functional loading (late failures due to excessive bone loss) in two patients
(one with history of periodontitis) at the three-year follow-up. Failures occurred in 4.5 × 6.0 mm and
5.0 × 6.0 mm implants, respectively, with a CIR of 1.43 and 2.17. The overall implant survival 36 months
after loading was 96.08%. There were no statistically significant differences (p = 0.62) between length
groups (100%, 91.3%, and 100% for implants 8.0 mm, 6.0 mm, and 5.0 mm in length, respectively).
No association was found between survival and failure groups, nor in any of the considered covariates,
as reported in Table 2.
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Table 2. Analysis of implant survival according to included study covariates. For all variables, values
are presented as n (%).
VARIABLE
Implant Survival Implant Failure
p-Value
n % n %
SEX
Male 20 100.00 0 0.00
0.51Female 29 93.55 2 6.45
SMOKING
No 41 97.62 1 2.38
0.32Yes 8 88.89 1 11.11
ASA STATUS
I 19 95.00 1 5.00
0.63II 30 96.77 1 3.23
ORAL HYGIENE
SESSIONS/YEAR 3.47 ± 0.32 2.88 ± 0.65 0.15
INTERPROXIMAL ORAL
HYGIENE
No 10 100.00 0 0.00
0.64Yes 39 95.12 2 4.88
HISTORY OF PERIODONTAL
DISEASE
No 13 92.86 1 7.14
0.47Yes 36 97.30 1 2.70
IMPLANT LENGTH
5 mm 21 100.00 0 0.00
0.626 mm 21 91.30 2 8.70
8 mm 7 100.00 0 0.00
IMPLANT DIAMETER
0.89
4 mm 2 100.00 0 0.00
4.5 mm 14 93.33 1 6.67
5 mm 28 96.55 1 3.45
6 mm 5 100.00 0 0.00
TYPE OF TOOTH
Premolar 13 100.00 0 0.00
0.55Molar 36 94.74 2 5.26
PROSTHETIC MATERIAL
Resin 6 85.71 1 14.29
0.25Porcelain 43 97.73 1 2.27
CROWN-TO-IMPLANT RATIO
<2 25 96.15 1 3.85
0.742–2.99 15 93.75 1 6.25
>2.99 9 100.00 0 0.00
3.3. Radiographic Bone Levels
Average crestal bone levels were stable between loading time and follow-up time, with a mean
∆CBL of 0.29 (0.46) mm and a mean ∆F-BIC of 0.12 (0.34) mm. Outcomes regarding CBL, F-BIC, RCBH,
and IBHG at each time interval are listed in Table 3.
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Table 3. RCBH (residual crestal bone height), IBHG (intra-sinus bone height gain), CBL (crestal bone
level), and F-BIC (first bone-to-implant contact point). Values are presented as mean ± SD (max;min),
or median(iqr) (max;min) at each time interval; SD = standard deviation; iqr = interquartile range.
PRE-OPERATIVE
AFTER
IMPLANT
PLACEMENT
p-Value AFTERLOADING p-Value
AT 3-YEAR
FOLLOW-UP p-Value
RCBH 5.20(1.41)[10.66;2.74]
10.27(2.15)
[15.08;7.81] <0.001
8.88(2.35)
[15.00;6.09] <0.001
7.59(1.97)
[14.27;5.23] <0.001
IBHG 4.84 ± 1.38[8.02;2.17]
3.96 ± 1.25
[6.33;1.19] <0.001
3.17 ± 1.13
[6.01;0.76] <0.001
CBL 1.87(0.93)[4.14;0.15]
1.46(0.81)
[3.39;0.45] <0.001
1.09(0.86)
[3.24;−1.92] <0.001
F-BIC 0.26(0.33)[1.08;−1.34]
0.37(0.45)
[1.92;−0.31] <0.001
Even if statistically significant differences between time intervals were found, we can assume these
variations as not clinically relevant: Average values obtained for CBL, F-BIC, RCBH, and IBHG after
three years of follow-up are compatible with bone levels’ stability. As implant length was considered a
clinically relevant covariate, the comparison for CBL, F-BIC, RCBH, and IBHG between length groups
is reported in Table 4: No statistically significant differences among length groups were found for any
of the variables at any time interval.
Table 4. Comparison of RCBH, IBHG, CBL, and F-BIC at each time interval, between length groups.
Values are presented as mean ± SD (max;min) or median(iqr) (max;min).
VARIABLE Overall 5 mm 6 mm 8 mm p-Value
RCBH
Pre-operative 5.20(1.41)[10.66;2.74]
5.43(1.13)
[10.66;2.97]
5.20(1.36)
[10.30;2.74]
4.92(2.86)
[7.68;4.07] 0.87
After implant
placement
10.27(2.15)
[15.08;7.81]
10.27(2.13)
[15.01;8.01]
10.12(2.31)
[15.08;7.95]
10.52(4.29)
[13.53;7.81] 0.97
After loading 8.88(2.35)[15.00;6.09]
9.54(1.91)
[12.16;6.34]
8.88(2.28)
[15.00;6.09]
8.83(3.12)
[10.84;6.26] 0.87
At 3-year follow-up 7.59(1.97)[14.27;5.23]
7.75(1.61)
[11.92;5.23]
7.34(1.97)
[14.27;5.69]
7.12(3.34)
[9.58;5.94] 0.73
IBHG
After implant
placement
4.84 ± 1.38
[8.02;2.17]
4.74 ± 1.27
[8.02;3.01]
4.84 ± 1.48
[7.69;2.17]
5.12 ± 1.53
[7.5;3.35] 0.82
After loading 3.96 ± 1.25[6.33;1.19]
3.81 ± 1.17
[6.2;1.98]
3.99 ± 1.36
[5.86;1.18]
4.3 ± 1.21
[6.33;3.01] 0.67
At 3-year follow-up 3.17 ± 1.13[6.01;0.76]
2.95 ± 1.07
[6.01;1.59]
3.35 ± 1.27
[5.2;0.76]
3.22 ± 0.75
[4.69;2.2] 0.51
CBL
After implant
placement
1.87(0.93)
[4.14;0.15]
1.89(1.22)
[4.14;0.15]
1.84(0.78)
[3.12;1.19]
1.87(1.01)
[3.11;0.83] 0.98
After loading 1.46(0.81)[3.39;0.45]
1.70(0.80)
[3.39;0.45]
1.38(0.81)
[2.58;0.70]
1.23(0.61)
[2.52;0.67] 0.28
At 3-year follow-up 1.09(0.86)[3.24;−1.92]
1.33(0.65)
[3.24;−0.04]
1.09(0.86)
[2.76;−1.92]
0.62(0.84)
[2.43;−0.00] 0.2
F-BIC
After loading 0.26(0.33)[1.08;−1.34]
0.26(0.40)
[1.08;0.00]
0.25(0.33)
[0.72;−1.34]
0.27(0.32)
[1.04;−1.03] 0.9
At 3-year follow-up 0.37(0.45)[1.92;−0.31]
0.36(0.35)
[1.42;0.00]
0.42(0.42)
[1.92;−0.31]
0.37(0.43)
[0.84;0.18] 0.59
3.4. Patients’ Level of Satisfaction
Seven days following the surgery, when questioned about their level of satisfaction with the
implant procedures, 14 patients (45.16%) gave a score between 9 and 10, 15 (48.39%) gave a score
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between 6 and 8, and two (6.45%) gave a score of 5; furthermore two patients referred to “being
hammered” and two reported “difficult in bearing”. At three-year recall appointment, when asked the
same question and whether they would undergo the surgery again, none of them retained a negative
memory of the entire procedure. On the contrary, they all said that they would undergo the treatment
again, and the average score was higher compared to the average score related to seven days after
surgery (Table 5). More precisely, 25 patients (80.65%) gave finally a score between 9 and 10 and six
(19.35%) gave a score between 7 and 8. Statistically significant differences (p < 0.001) were found
between the first and second time of evaluation (Table 5).
Table 5. Comparison between satisfaction scores given seven days after surgery and given at three-year
recall appointment. Unit of comparison was the patient. Values are presented as median(iqr) (max;min).
PRE-OPERATIVE AT 3-YEAR FOLLOW-UP p-Value
SATISFACTION
SCORES 8(2) [10;5] 9(1) [10;7] <0.001
4. Discussion
According to a traditional point of view, a residual bone height of at least 5.0 mm in the atrophic
posterior maxilla is considered a predictable option for implant placement when done in tandem
with a sinus augmentation using the OSFE technique [17–19]. A few studies in the literature claimed
predictability for standard implants’ (longer than 8.0 mm) placement in conjunction with an immediate
OSFE procedure in RCBH even less than 4.0 mm [49,50]. Nevertheless, the majority of the authors
reported lower survival in cases of implant placement in RCBH less than 5.0 mm, strongly suggesting
delayed implant placement in such cases, to allow proper graft healing and to achieve primary implant
stability [20,51–54].
In addition, to facilitate the placement of implants in minimal volumes of crestal bone, several
recent studies have shown that short implants (8.0 and 6.0 mm in length) with rough surface are
capable, within certain limits, of tolerating high CIR (shown below), providing stable bone levels as
well as implant survival comparable to those of standard implants in the long term [41–43,55,56].
It was also demonstrated that the Schneiderian membrane can properly support elevation of
4.0 mm without perforation [57]. On this basis, the use of short implants, requiring only a minimal
amount of sinus floor elevation, while reducing the risk of sinus perforation [58], might represent the
most prudent and conservative surgical approach to rehabilitate the perennially problematic atrophic
posterior maxilla. The use of short implants in conjunction with the OSFE technique in the treatment
of RCBH equal or inferior to 5.0 mm was proposed with favorable results [45]. It is noted, however,
that there is still a lack of data regarding the long-term efficacy of this therapeutic solution.
In this study, favorable outcomes for implant survival and bone levels’ stability were found at
three-year follow-up, despite the prevalence of CIR > 2 in almost half of the sample size and the
presence of patients with history of periodontitis accounting for a high percentage of implants. These
findings are consistent with those of two recently published studies, where short implants had been
placed in a similar anatomical setting. A randomized controlled trial (RCT) by Si et al. [45] followed
41 short implants placed in association with OSFE in 41 patients who had an initial average RCBH
of 4.63 mm. After three years, an implant survival of 95.2% and 95% and an IBHG of 3.17 mm and
3.07 mm were reported for a group with and another group without grafting, respectively. A study
by Teng et al. [46], compared to the present investigation, presented slight differences; specifically,
the crestal sinus elevation methodology used trephine burs instead of osteotomes. In that study,
50 short implants were placed in extremely reabsorbed maxilla and reported a survival rate of 100%,
with an IBHG of 4.4 mm and a final RCBH of 7.77 mm after a short-term follow-up.
It was recently demonstrated [59] that the type of implant-abutment connection and the implant
body design may play an important role in peri-implant soft tissue health and hard tissue stability.
The locking-taper connection and the plateau-body design of the implants utilized in the present study
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seem to assure a functional sealing of the implant-abutment connection [35] and create a favorable
influence on bone level stability, even in the presence of high CIR [29,30]. Consequently, the implant
design results in proper distribution of augmented loadings and lateral forces, which, in turn, preserves
the limited amount of crestal bone available in the atrophic posterior maxilla, despite the presence of
single-crown restorations characterized by increased CIR [42]. Therefore, multiple splinted crowns may
no longer be considered as an essential therapeutic choice in presence of short and ultra-short implants
with a similar design [42]. Nevertheless, more studies with a longer follow-up and larger samples
are necessary to validate these approaches. In the study at hand, the 5.0-mm implants presented a
significantly higher mean CIR compared to the other length groups and no failures after three years.
This might suggest that not only short but also ultra-short implants are able to support large single
crowns and can be considered a rational treatment for the atrophic posterior maxilla. That said, these
findings must take into account that studies regarding the use of 5.0-mm-length implants to support
single crowns are currently scarce and heterogeneous [29,30,38,60].
It also must be stressed that all patients in the study underwent regular supportive care in the form
of full-mouth ultrasonic debridement every four months throughout the study period and that proper
periodontal treatment prior to implant placement was the standard of care, necessary for patients
with active periodontal disease: For this group of patients, a strict maintenance program is even more
strongly recommended for the long-term success of short implants [33].
Another point related to patients’ management is the premedication with antibiotics before and
after implant placement to prevent infections. Even if the routine use of pre- and post-operative
antibiotics in oral surgery remains controversial [34], we assumed that the surgical procedures adopted
in this study presented high risk of infection. Thus, antibiotic prophylaxis was required [61].
The main complication related to the OSFE procedure described in literature [62] is the repeated
hammering of the osteotome, which is intended to compact the column of bone substitute material
while using it to create a controlled fracture of the sinus floor. This process causes a localized
apical dislocation of the sinus floor while maintaining the integrity of the Schneiderian membrane.
Furthermore, tapping with a hand mallet may induce BPPV (benign paroxysmal positional vertigo):
This may be surprising and somewhat unpleasant for patients who have never experienced this
form of vertigo [62–64]. In our study, even though some patients referred to “being hammered” or
having “difficulty in bearing”, when asked about their experience seven days after surgery, none of
them actually reported experiencing vertigo. At the three-year recall appointment, none of them had
retained a negative memory of the entire procedure: All said that they would readily undergo the
same procedure in order to obtain the same benefits.
Finally, our study does present some critical issues relative to its retrospective nature: The small
sample size, a three-year follow-up evaluation, a non-homogeneous distribution among implant length
groups, and a single center (the University Dental Clinic). On the other hand, a one-year interval
(January 2014–January 2015) for patient recruitment could be a favorable point in excluding any
significant variations of technique. Most of the patients enrolled in the study were characterized by a
history of periodontal disease; this was potentially a critical limitation for the study, but it was not a
significant issue for implant survival.
Despite the limitations discussed above, the main strength of our study comprises a positive
assessment: Three years after loading, a high proportion of locking-taper implants (96.08%) placed in
conjunction with an internal sinus floor elevation technique, restored with single crowns and having a
moderately disproportionate CIR, survived with stable crestal bone levels. However, further long-term
investigations (five-year follow-up or longer) with a prospective approach, a major homogeneity in
length-group distribution, and a larger sample size are needed to corroborate our results on ultra-short
implants in the posterior atrophic maxilla.
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5. Conclusions
Within the limits of the present retrospective short-term study, our clinical and radiographic
outcomes suggested that short and ultra-short locking-taper implants, placed in conjunction with
an ISL technique and restored with single crowns, can be considered a predictable treatment for
edentulous posterior maxillary regions with RCBH less than 6.0 mm.
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Abbreviations
RCBH Residual crestal bone height
OSFE Osteotome sinus floor elevation
ISL Internal sinus lift technique
ASA American Society of Anesthesiologists
CBCT Cone beam computed tomography
CIR Crown-to-implant ratio
IAI Implant-abutment interface
CBL Crestal bone level
F-BIC First bone-to-implant contact
∆-CBL Average bone loss
∆F-BIC Average apical shift of the first bone-to-implant contact point position
SFL Sinus floor level
av Average
IBHG Intra-sinus bone height gain
BPPV Benign paroxysmal positional vertigo
SD Standard deviation
iqr Interquartile range
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